Aquawalk Group Berhad (0380.KL) stock: key figures, P/E, revenue and dividend
Consumer Discretionary · Malaysia
Price
0.13 MYR
Market cap
230.38 m MYR
P/E (2025)
6.19
P/S (2025)
2.06
Dividend yield
12.00 %
Net margin
33.35 %
Return on equity (ROE)
15.95 %
Return on assets (ROA)
9.97 %
Aquawalk Group Berhad financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 103.21 m MYR | 111.66 m MYR |
| Gross profit | 58.33 m MYR | 66.10 m MYR |
| Operating income | 41.33 m MYR | 50.42 m MYR |
| EBIT | 46.42 m MYR | 54.13 m MYR |
| Net income | 48.86 m MYR | 37.24 m MYR |
| Diluted EPS – continuing operations | 0.03 MYR | 0.02 MYR |
Full history since 2021, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Aquawalk Group Berhad
Aquawalk Group Berhad is an investment holding company, engages in development and operation of flagship private aquaria. It also designs, develops, and maintains third-party aquaria. The company was incorporated in 2024 and is based in Kuala Lumpur, Malaysia.
More stocks
- Hotel Holiday Garden (2702.TW)
- Broken Hill Gold Ltd (BH6.AX)
- POSITRON CORP (POSC)
- PRECISION OPTICS CORPORATION, INC. (POCI)
- Zenix Robotics Co.,Ltd (381620.KQ)
- XSpray Pharma AB (XSPRAY.ST)
- Frontier Lithium Inc (FL.V)
- Hotron Precision Electronic Industrial Co Ltd (3092.TW)
- Topview Optronics Corporation (6556.TWO)
- Tifa Finance Tbk (TIFA.JK)
- Anfield Resources Inc (AEC.V)
- Xilio Therapeutics, Inc. (XLO)
Not investment advice. All data without warranty, price as of 16.11.2026. Details in the risk notice.